Cleared Abbreviated

Visi Mobile Monitoring System, Visi Mobile Chest Sensor (K142827) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through the Abbreviated 510(k) pathway - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2015
Decision
293d
Days
Class 2
Risk

K142827 is an FDA 510(k) clearance for the Visi Mobile Monitoring System, Visi Mobile Chest Sensor. Classified as Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms) (product code MHX), Class II - Special Controls.

Submitted by Sotera Wireless, Inc. (San Diego, US). The FDA issued a Cleared decision on July 20, 2015 after a review of 293 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1025 - the FDA cardiovascular device oversight framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Sotera Wireless, Inc. devices

Submission Details

510(k) Number K142827 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 30, 2014
Decision Date July 20, 2015
Days to Decision 293 days
Submission Type Abbreviated
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
168d slower than avg
Panel avg: 125d · This submission: 293d
Pathway characteristics
Standards-based clearance path.

Device Classification

Product Code MHX Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1025
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MHX Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms)

All 197
Devices cleared under the same product code (MHX) and FDA review panel - the closest regulatory comparables to K142827.
PATIENT MONITORS VARIOUS MODELS
K151812 · Philips Medical Systems · Jan 2016
Panorama Patient Monitoring Network
K150082 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Sep 2015
V Series Monitoring System (including V12 and V21 Monitors)
K150352 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Sep 2015
IM60/IM70 PATIENT MONITOR
K131971 · Edan Instruments, Inc. · Mar 2014
PHILIPS SURESIGNS CENTRAL
K131032 · Philips Medical Systems · Aug 2013
IMEC, IPM AND BENEVIEW T1 PATIENT MONITORS
K123074 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Jul 2013